Impurity Identification and Scale-Up of a Novel Glycopeptide Antibiotic
Shang Jiao,Dongliang Guan,Lili Xu,Bo Liu,Weiwei Shi,Jian Li,Feng Tang,Wei Huang
DOI: https://doi.org/10.1021/acs.oprd.1c00064
2021-10-14
Abstract:A variety of novel glycopeptide antibiotics have been developed to combat the drug-resistant bacterial strains. Previously, we reported a series of vancomycin derivatives that are modified with lipid tails and extra sugars. SM-V-61, as one of the vancomycin analogues with a trifluoromethyl-biphenyl fragment and galactose, showed enhanced antibacterial activity, improved PK/PD, better water solubility, and safety. However, the deficient synthetic procedure, lower yield, and complicated impurities hindered the further development of the drug candidate SM-V-61. Herein, we reported a further study on SM-V-61 impurity analysis and process optimization. We first synthesized and identified a variety of impurities and established the analytical method for quality analysis and control of SM-V-61. Based on the defined analytical method, we optimized the synthetic procedure for SM-V-61 and operated the synthesis on 30–40 and 500–600 g scales in the laboratory and manufacturing workshop, respectively.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.oprd.1c00064.Method A-I for analytical detection of SM-V-61; HPLC and impurities of SM-V-61; establishment of analytical detection method J–O for impurities; HPLC profile of impurity mixture with analytical method under different mobile phase buffers; HPLC profiles of SM-V-61 synthesis under various conditions; HPLC, LC-MS, and NMR spectra (PDF)This article has not yet been cited by other publications.
chemistry, organic, applied